Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
BIOMARKER DEVELOPMENT FOR A PHASE II STUDY OF...
Conference

BIOMARKER DEVELOPMENT FOR A PHASE II STUDY OF COMBINATION EPIGENETIC THERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

Authors

Wrangle JM; Juergens RA; Vendetti F; Coleman B; Sebree R; Rudek M; Herman J; Rudin C; Brock MV

Volume

6

Pagination

pp. S1101-S1101

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

June 1, 2011

Conference proceedings

JOURNAL OF THORACIC ONCOLOGY

Issue

6

ISSN

1556-0864